Literature DB >> 10743285

Clinical safety issues of measles, mumps and rubella vaccines.

M A Afzal1, P D Minor, G C Schild.   

Abstract

The clinical safety of measles and measles-mumps-rubella vaccines has been questioned in recent reports that propose a possible link between measles virus or measles vaccines and the occurrence of juvenile Crohn disease and autism. This article reviews the outcomes of several laboratory investigations which were carried out independently to identify the presence or absence of measles virus in the intestinal tissues derived from cases of inflammatory bowel disease. One research group reported the presence of measles virus particles and genomic RNA in inflammatory bowel disease tissues, but this could not be confirmed by other groups, despite use of techniques that are highly specific and sensitive for the detection of measles virus nucleic acid in clinical specimens down to the molecular level. Based on the published data reviewed here, it can be concluded that there is no direct association between measles virus or measles vaccines and the development of Crohn disease, a conclusion which is supported by most epidemiological findings.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10743285      PMCID: PMC2560675     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  4 in total

Review 1.  Detection of persistent measles virus infection in Crohn's disease: current status of experimental work.

Authors:  S Ghosh; E Armitage; D Wilson; P D Minor; M A Afzal
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  Imitation dynamics predict vaccinating behaviour.

Authors:  Chris T Bauch
Journal:  Proc Biol Sci       Date:  2005-08-22       Impact factor: 5.349

3.  Managing controversy through consultation: a qualitative study of communication and trust around MMR vaccination decisions.

Authors:  Robert McMurray; Francine M Cheater; Anna Weighall; Carolyn Nelson; Martin Schweiger; Suzanne Mukherjee
Journal:  Br J Gen Pract       Date:  2004-07       Impact factor: 5.386

Review 4.  Yellow fever vector live-virus vaccines: West Nile virus vaccine development.

Authors:  J Arroyo; C A Miller; J Catalan; T P Monath
Journal:  Trends Mol Med       Date:  2001-08       Impact factor: 11.951

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.